These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 35653726)

  • 1. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 2. Initiation of Continuous Glucose Monitoring Is Linked to Improved Glycemic Control and Fewer Clinical Events in Type 1 and Type 2 Diabetes in the Veterans Health Administration.
    Reaven PD; Newell M; Rivas S; Zhou X; Norman GJ; Zhou JJ
    Diabetes Care; 2023 Apr; 46(4):854-863. PubMed ID: 36807492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Glucose Monitor Use Prevents Glycemic Deterioration in Insulin-Treated Patients with Type 2 Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    Diabetes Technol Ther; 2022 May; 24(5):332-337. PubMed ID: 35104159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study.
    Charleer S; Mathieu C; Nobels F; De Block C; Radermecker RP; Hermans MP; Taes Y; Vercammen C; T'Sjoen G; Crenier L; Fieuws S; Keymeulen B; Gillard P;
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1224-1232. PubMed ID: 29342264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
    Gilbert TR; Noar A; Blalock O; Polonsky WH
    Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
    [No Abstract]   [Full Text] [Related]  

  • 9. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Continuous Glucose Monitoring Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes.
    Salam M; Bailey R; Calhoun P; McGill JB; Bergenstal RM; Price D; Beck RW
    Diabetes Technol Ther; 2023 Mar; 25(3):178-185. PubMed ID: 36472504
    [No Abstract]   [Full Text] [Related]  

  • 12. Real-time continuous glucose monitoring improves glycemic control and reduces hypoglycemia: Real-world data.
    Kant R; Antony MA; Geurkink D; Gilreath N; Chandra L; Zipprer E; Munir KM; Chandra R; Parker VG; Verma V
    Prim Care Diabetes; 2022 Dec; 16(6):786-790. PubMed ID: 36117090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential associations of risk factors with severe and non-severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin-treated type 1 diabetes and type 2 diabetes.
    He Y; Kunutsor SK; Kingsnorth AP; Gillies C; Choudhary P; Khunti K; Zaccardi F
    Diabetes Obes Metab; 2024 Aug; 26(8):3361-3370. PubMed ID: 38826105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial.
    Raghinaru D; Calhoun P; Bergenstal RM; Beck RW
    Diabetes Technol Ther; 2022 Dec; 24(12):868-872. PubMed ID: 35920822
    [No Abstract]   [Full Text] [Related]  

  • 16. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes.
    Toschi E; Slyne C; Sifre K; O'Donnell R; Greenberg J; Atakov-Castillo A; Carl S; Munshi M
    Diabetes Care; 2020 Oct; 43(10):2349-2354. PubMed ID: 32461211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes.
    Chan CL; Pyle L; Morehead R; Baumgartner A; Cree-Green M; Nadeau KJ
    Pediatr Diabetes; 2017 Sep; 18(6):470-477. PubMed ID: 27503277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients.
    Cosson E; Hamo-Tchatchouang E; Dufaitre-Patouraux L; Attali JR; Pariès J; Schaepelynck-Bélicar P
    Diabetes Metab; 2009 Sep; 35(4):312-8. PubMed ID: 19560388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.